Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
- PMID: 23614584
- PMCID: PMC3701945
- DOI: 10.1056/NEJMoa1109400
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Abstract
Background: Recent studies in animals have shown a mechanistic link between intestinal microbial metabolism of the choline moiety in dietary phosphatidylcholine (lecithin) and coronary artery disease through the production of a proatherosclerotic metabolite, trimethylamine-N-oxide (TMAO) VSports手机版. We investigated the relationship among intestinal microbiota-dependent metabolism of dietary phosphatidylcholine, TMAO levels, and adverse cardiovascular events in humans. .
Methods: We quantified plasma and urinary levels of TMAO and plasma choline and betaine levels by means of liquid chromatography and online tandem mass spectrometry after a phosphatidylcholine challenge (ingestion of two hard-boiled eggs and deuterium [d9]-labeled phosphatidylcholine) in healthy participants before and after the suppression of intestinal microbiota with oral broad-spectrum antibiotics. We further examined the relationship between fasting plasma levels of TMAO and incident major adverse cardiovascular events (death, myocardial infarction, or stroke) during 3 years of follow-up in 4007 patients undergoing elective coronary angiography V体育安卓版. .
Results: Time-dependent increases in levels of both TMAO and its d9 isotopologue, as well as other choline metabolites, were detected after the phosphatidylcholine challenge. Plasma levels of TMAO were markedly suppressed after the administration of antibiotics and then reappeared after withdrawal of antibiotics. Increased plasma levels of TMAO were associated with an increased risk of a major adverse cardiovascular event (hazard ratio for highest vs V体育ios版. lowest TMAO quartile, 2. 54; 95% confidence interval, 1. 96 to 3. 28; P<0. 001). An elevated TMAO level predicted an increased risk of major adverse cardiovascular events after adjustment for traditional risk factors (P<0. 001), as well as in lower-risk subgroups. .
Conclusions: The production of TMAO from dietary phosphatidylcholine is dependent on metabolism by the intestinal microbiota. Increased TMAO levels are associated with an increased risk of incident major adverse cardiovascular events. (Funded by the National Institutes of Health and others. ) VSports最新版本. .
"VSports" Figures
Comment in
-
Gut microbiota, the genome, and diet in atherogenesis.N Engl J Med. 2013 Apr 25;368(17):1647-9. doi: 10.1056/NEJMe1302154. N Engl J Med. 2013. PMID: 23614591 No abstract available.
-
V体育平台登录 - Risk factors: intestinal microbiota: "a new direction in cardiovascular research".Nat Rev Cardiol. 2013 Jul;10(7):363. doi: 10.1038/nrcardio.2013.75. Epub 2013 May 14. Nat Rev Cardiol. 2013. PMID: 23670614 No abstract available.
-
Metabolismo de la fosfatidilcolina por la microbiota intestinal y riesgo cardiovascular.Rev Clin Esp (Barc). 2014 Jan-Feb;214(1):46-8. doi: 10.1016/j.rce.2013.07.006. Rev Clin Esp (Barc). 2014. PMID: 24624423 Spanish. No abstract available.
"V体育2025版" References
-
- Patterson KY, Bhagwat SA, Williams JR, Howe JC, Holden JM. USDA database for the choline content of common foods: release two. 2008 ( http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/Choline/Choln02...)
-
- Zhang AQ, Mitchell SC, Smith RL. Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol. 1999;37:515–520. - PubMed
-
- Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 2006;26:229–250. - V体育官网入口 - PMC - PubMed
Publication types (VSports最新版本)
MeSH terms
- "VSports" Actions
- "V体育ios版" Actions
- Actions (VSports)
- V体育官网入口 - Actions
- Actions (V体育2025版)
- Actions (VSports)
- Actions (V体育官网)
- Actions (V体育官网)
Substances
- Actions (V体育平台登录)
- "V体育安卓版" Actions
- V体育ios版 - Actions
Grants and funding
- 1P20HL113452/HL/NHLBI NIH HHS/United States
- R01HL103866/HL/NHLBI NIH HHS/United States
- R01 HL103931/HL/NHLBI NIH HHS/United States
- R01 HL103866/HL/NHLBI NIH HHS/United States
- P01 HL076491/HL/NHLBI NIH HHS/United States
- P01HL098055/HL/NHLBI NIH HHS/United States
- "VSports手机版" R01HL103931/HL/NHLBI NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- UL1TR000439/TR/NCATS NIH HHS/United States (V体育官网)
- VSports最新版本 - T32 GM007250/GM/NIGMS NIH HHS/United States
- P20 HL113452/HL/NHLBI NIH HHS/United States
- R01 DK080732/DK/NIDDK NIH HHS/United States
- R01DK080732/DK/NIDDK NIH HHS/United States
- P01 HL098055/HL/NHLBI NIH HHS/United States
- P01HL076491/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical